March 04, 2010

New Morphoplant patent granted for drug-delivery applications

Morphoplant has received notification from the European Patent Office that its application “METHOD FOR PRODUCING A PRODUCT HAVING A POLYMER MATRIX, IMPLANTS MADE THEREOF AND USE THEREOF” (EP patent application 07857884.6) has been granted. The new patent includes 12 claims covering compositions and methods for producing a polymer matrix from polylactic acid, polyglycolic acid or copolymers in combination with cytostatic agents, antibiotics or growth factors like BMP-2. This wide-ranging patent may be broadly used for the production of drug delivering devices for therapeutic applications.
Morphoplant has also filed for patent protection in USA, Australia, Asia and other regions of the world. We expect patents to be granted upon completion of the patent application examination process.